A trans-dominant mutation in human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp41 inhibits membrane fusion when expressed in target cells

References

• Blumenthal R., Schoch C., Puri A., Clague M. J. A dissection of steps leading to viral envelope protein-mediated membrane fusion. Annals of the New York Academy of Sciences 1991; 635: 285–296
   PubMed Web of Science ®Google Scholar
• Bosch M. L., Earl P. L., Fargnoli K., Picciafuoco S., Giombini, Wong F., Staal F., Franchini G. Identification of the fusion peptide of primate immunodeficiency viruses. Science 1989; 244: 694–697
   PubMed Web of Science ®Google Scholar
• Buchschacher G. L., Jr., Freed E. O., Panganiban A. T. Cells induced to express a human immunodeficiency virus type 1 envelope gene mutant inhibit the spread of wild-type virus. Human Gene Therapy 1992; 3: 391–397
   PubMed Web of Science ®Google Scholar
• Dalgleish A. G., Beverley P. C. L., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984; 312: 763–767
   PubMed Web of Science ®Google Scholar
• Dimitrov D. S., Golding H., Blumenthal R. Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes. AIDS Research and Human Retroviruses 1991; 7: 799–805
   Google Scholar
• Dimitrov D. S., Hillman K., Manischewitz J., Blumenthal R., Golding H. Correlation between kinetics of soluble CD4 interactions with HIV-1-envelope-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS. AIDS 1992; 6: 249–256
   Google Scholar
• Earl P. L., Hügin A. W., Moss B. Removal of cryptic poxvirus transcription termination signals from the human immuno-deficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. Journal of Virology 1990; 64: 2448–2451
   PubMed Web of Science ®Google Scholar
• Earl P. L., Koenig S., Moss B. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. Journal of Virology 1991; 65: 31–41
   PubMedGoogle Scholar
• Felser J. M., Klimkait T., Silver J. A syncytia assay for human immunodeficiency virus type 1 (HIV-1) envelope protein and its use in studying HIV-1 mutants. Virology 1989; 170: 566–570
   Google Scholar
• Freed E. O., Risser R. Identification of conserved residues in the human immunodeficiency virus type 1 principal neutralizing determinant that are involved in fusion. AIDS Research and Human Retroviruses 1991; 7: 807–811
   Google Scholar
• Freed E. O., Myers D. J., Risser R. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160. Journal of Virology 1989; 63: 4670–4675
   Google Scholar
• Freed E. O., Myers D. J., Risser R. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proceedings of the National Academy of Sciences 1990; 87: 4650–4654
   PubMed Web of Science ®Google Scholar
• Freed E. O., Delwart E. L., Buchschacher G. L., Jr, Panganiban A. T. A mutation in the human immuno-deficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proceedings of the National Academy of Sciences, USA 1992; 89: 70–74
   PubMed Web of Science ®Google Scholar
• Gabuzda D. H., Lever A., Terwilliger E., Sodroski J. Effects of deletions in the cytoplasmic domain on biological functions of HIV-1 envelope glycoproteins. Journal of Virology 1992; 66: 3306–3315
   Google Scholar
• Gallaher W. R. Detection of a fusion peptide sequence in the transmembrane protein of the human immunodeficiency virus. Cell 1987; 50: 327–328
   PubMed Web of Science ®Google Scholar
• Gallaher W. R., Ball J. M., Garry R. F., Griffin M. C., Montelaro R. C. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Research and Human Retroviruses 1989; 5: 431–440
   PubMed Web of Science ®Google Scholar
• Gething M.-J., Doms R. W., York D., White J. Studes on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. Journal of Cell Biology 1986; 102: 11–23
   PubMed Web of Science ®Google Scholar
• Gonzalez-Scarano F., Waxham M., Ross A., Hoxie J. Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins. AIDS Research and Human Retroviruses 1987; 3: 245–252
   PubMed Web of Science ®Google Scholar
• Helseth E., Kowalski M., Gabuzda D., Olshevsky U., Haseltine W., Sodroski J. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. Journal of Virology 1990a; 64: 2416–2420
   Google Scholar
• Helseth E., Olshevsky U., Gabuzda D., Ardman B., Haseltine W., Sodroski J. Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion. Journal of Virology 1990b; 64: 6314–6318
   Google Scholar
• Hillman K., Shapira-Nahor O., Gruber M. F., Hooley J., Manischewitz J., Seeman R., Yujcic L., Geyer S. J., Golding H. Chemically induced CD4 mutants of a human T cell Line. Journal of Immunology 1990; 144: 2131–2139
   Google Scholar
• Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.-C., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984; 312: 767–768
   PubMed Web of Science ®Google Scholar
• Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W. C., Terwilliger E., Dayton A., Rosen C., Haseltine W., Sodroski J. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 1987; 237: 1351–1355
   PubMed Web of Science ®Google Scholar
• Kowalski M., Bergeron L., Dorfman T., Haseltine W., Sodroski J. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein. Journal of Virology 1991; 65: 281–291
   PubMed Web of Science ®Google Scholar
• Lifson J. D., Feinberg M. B., Reyes G. R., Rabin L., Banapour B., Chakrabarti S., Moss B., Wong-Staal F., Steiner K. S., Engleman E. G. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature 1986; 323: 725–728
   PubMed Web of Science ®Google Scholar
• Mackett M., Smith G. L., Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 1984; 49: 857–864
   PubMed Web of Science ®Google Scholar
• Maddon P. J., Dalgleish A. G., McDougal J. S., Clapham P. R., Weiss R. A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986; 47: 333–348
   PubMed Web of Science ®Google Scholar
• McDougal J. S., Kennedy M., Sligh J., Cort S., Mowle A., Nicholson J. Binding of the HTLV-III/LAV to T4+T cells by a complex of the 110 K viral protein and the T4 molecule. Science 1986; 231: 382–385
   PubMed Web of Science ®Google Scholar
• Moss B., Earl P. L., Cooper N. Expression of proteins in mammalian cells using vaccinia. Current Protocols in Molecular Biology, F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, K. Struhl. Wiley, New York 1987; 16.15.1–16.18.10
   Google Scholar
• Ratner L., Haseltine W., Patarca R., Livak K. J., Starcich B., Josephs S. F., Doran E. R., Rafalski J. A., Whitehorn E. A., Baumeister K., Ivanoff L., Petteway S. R., Jr, Pearson M. L., Lautenberger J. A., Papas T. S., Ghrayeb J., Chang N. Y., Gallo R. C., Wong-Staal F. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985; 313: 277–284
   PubMed Web of Science ®Google Scholar
• Schoch C., Blumenthal R. Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion. Journal of Biological Chemistry 1993; 268: 9267–9274
   PubMed Web of Science ®Google Scholar
• Sodroski J., Goh W. C., Rosen C., Campbell K., Haseltine W. A. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 1986; 322: 470–474
   PubMed Web of Science ®Google Scholar
• Wain-Hobson S., Sonigo P., Danos O., Cole S., Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell 1985; 40: 9–17
   PubMed Web of Science ®Google Scholar
• White J. M. Viral and cellular membrane fusion proteins. Annual Review of Physiology 1990; 52: 675–697
   PubMed Web of Science ®Google Scholar